GEHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
GE Healthcare Technologies Inc is not a strong buy for a beginner, long-term investor at this moment. While the company has shown revenue growth and positive analyst sentiment, the recent financial performance shows declining net income, EPS, and gross margin. Additionally, technical indicators suggest a neutral to bearish trend, and hedge funds are selling the stock. Given these factors, it is better to hold off on investing until there are clearer positive signals or improved financial performance.
The MACD is negatively expanding (-0.137), indicating bearish momentum. RSI is at 36.4, which is neutral but leaning towards oversold territory. Moving averages are converging, showing no clear trend. The stock is trading below the pivot level (80.72), with key support at 77.328 and resistance at 84.112.
Analysts have raised price targets, with some firms maintaining a Buy or Overweight rating. The company reported solid Q4 revenue growth and has a strong order backlog. GE Healthcare was named one of Fortune's Most Admired Companies for 2026, and a quarterly dividend reflects a commitment to shareholder returns.
Hedge funds are selling the stock, with a 129.92% increase in selling activity last quarter. Technical indicators do not show a strong bullish trend, and the stock is trading below key pivot levels.
In Q4 2025, revenue increased by 7.13% YoY to $5.698 billion. However, net income dropped by 18.31% YoY to $589 million, EPS fell by 17.83% YoY to 1.29, and gross margin decreased by 7.22% YoY to 39.68%.
Analysts have raised price targets recently, with targets ranging from $85 to $105. The sentiment is cautiously optimistic, with firms citing a solid Q4 beat, a healthy demand environment, and a positive 2026 outlook. However, some analysts maintain neutral ratings, reflecting mixed views on risk-reward.
